Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
Y

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With HER2+ Locally Advanced/Metastatic BC: OS Results of a Phase 3 Randomized Trial (JBCRG-M05: PRECIOUS)"

By Insights from 2023 ASCO® Annual Meeting FEATURING Yutaka Yamamoto
By Insights from 2023 ASCO® Annual Meeting FEATURING Yutaka Yamamoto
381 views
June 6, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Breast
14:37

ASCO® 2023 Insights: "Practical Implications of SONIA Trial Results …

Insights from 2023 ASCO® Annual Meeting

N. El Saghir

534 views
09:50

ASCO® 2023 Insights: "Randomised Open-Label Phase II FAIM Study - In…

Insights from 2023 ASCO® Annual Meeting

I. Browne

87 views
09:52

ASCO® 2023 Insights: "Real-World Patient Characteristics & Treatment…

Insights from 2023 ASCO® Annual Meeting

J. Meisel

285 views
29:14

ASCO® 2023 Insights: "Breast Cancer Surgery - Too Much, Too Little, …

Insights from 2023 ASCO® Annual Meeting

S. Khan

136 views
06:37

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribo…

Insights from 2023 ASCO® Annual Meeting

N. McAndrew

307 views
04:27

ASCO® 2023 Insights: "BRCA Alterations - Beyond Breast and Ovarian C…

Insights from 2023 ASCO® Annual Meeting

T. Yap

141 views
04:05

ASCO® 2023 Insights: "evERA Breast Cancer Phase III Study - Giredest…

Insights from 2023 ASCO® Annual Meeting

E. Mayer

273 views
06:17

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO Stud…

Insights from 2023 ASCO® Annual Meeting

A. Van Ommen - Nijhof

117 views
09:35

ASCO® 2023 Insights: "Primary Outcome Analysis of the Phase 3 SONIA …

Insights from 2023 ASCO® Annual Meeting

N. Wortelboer

68 views
08:51

ASCO® 2023 Insights: "Effects of Ovarian Ablation or Suppression on …

Insights from 2023 ASCO® Annual Meeting

R. Gray

333 views
07:47

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capeci…

Insights from 2023 ASCO® Annual Meeting

C. Bohnenkamp

363 views
23:03

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Are and…

Insights from 2023 ASCO® Annual Meeting

E. Stringer-Reasor

378 views
10:02

ASCO® 2023 Insights: "Double-Blind, Placebo-Controlled Phase 3 AIPAC…

Insights from 2023 ASCO® Annual Meeting

N. Ibrahim

60 views
05:36

ASCO® 2023 Insights: "Prognostic Impact of Adjuvant Endocrine Therap…

Insights from 2023 ASCO® Annual Meeting

Y. Takahashi

104 views
08:41

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Rand…

Insights from 2023 ASCO® Annual Meeting

P. Conte

760 views
12:23

ASCO® 2023 Insights: Role of Endocrine Therapy Timing Intake in Pts …

Insights from 2023 ASCO® Annual Meeting

S. Giacchetti

644 views
07:17

ASCO® 2023 Insights: "Primary Results of NCCH1607/PATHWAY, an Asian …

Insights from 2023 ASCO® Annual Meeting

T. Kogawa

111 views
07:28

ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing Primar…

Insights from 2023 ASCO® Annual Meeting

T. Shien

355 views
13:15

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Arms in…

Insights from 2023 ASCO® Annual Meeting

D. Wolf

104 views
13:20

ASCO® 2023 Insights: "lidERA Breast Cancer Phase III Adjuvant Study …

Insights from 2023 ASCO® Annual Meeting

C. Geyer

345 views
10:50

ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarker for…

Insights from 2023 ASCO® Annual Meeting

W. Audeh

239 views
16:42

ASCO® 2023 Insights: "Late Recurrences in ER+ Breast Cancer - What E…

Insights from 2023 ASCO® Annual Meeting

M. Gnant

643 views
11:31

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, TROPI…

Insights from 2023 ASCO® Annual Meeting

P. Tarantino

8.2K views
05:27

ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial - Phar…

Insights from 2023 ASCO® Annual Meeting

C. Becherini, L. Livi

207 views
23:58

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials Inclu…

Insights from 2023 ASCO® Annual Meeting

H. Rugo, K. Jhaveri

1.9K views
28:36

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials Inclu…

Insights from 2023 ASCO® Annual Meeting

H. Rugo, K. Jhaveri

4.8K views
13:35

ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Trial - …

Insights from 2023 ASCO® Annual Meeting

N. El Saghir

267 views
06:57

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

830 views
06:55

ASCO® 2023 Insights: "Comparative OS of Pts in Trials of CKD4/6i in …

Insights from 2023 ASCO® Annual Meeting

C. Kappel

325 views
08:00

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuv…

Insights from 2023 ASCO® Annual Meeting

M. Ignatiadis

217 views
11:13

ASCO® 2023 Insights: "Are We Splitting HERs? The Highs and Lows"

Insights from 2023 ASCO® Annual Meeting

D. Rimm

231 views
16:08

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNBC"

Insights from 2023 ASCO® Annual Meeting

H. Han

856 views
08:38

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abemacicli…

Insights from 2023 ASCO® Annual Meeting

R. Patel

817 views
07:47

ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Risk' Diseas…

Insights from 2023 ASCO® Annual Meeting

J. Plichta

293 views
02:59

ASCO® 2023 Insights: "Oral Elacestrant vs. Standard-of-Care in ER+/H…

Insights from 2023 ASCO® Annual Meeting

V. Kaklamani

115 views
09:32

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - S…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

705 views
04:28

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant Sacit…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

2.3K views
12:48

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes …

Insights from 2023 ASCO® Annual Meeting

M. Tesch

119 views
05:21

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With HER2+ …

Insights from 2023 ASCO® Annual Meeting

Y. Yamamoto

381 views